Inspire Medical Systems, Inc. (INSP)
$68.86-3.68%Close
SELLRECOVERY · day 89
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.0B
- Beta
- 0.73
- P/E (TTM)
- 14.77
- Short % float
- 15.44%
- Days to cover
- 4.6
- SI change
- +6.8%
- 1W
- +0.97%
- 1M
- -7.35%
- vs SPY 1W
- +1.11%
- vs SPY 1M
- -9.85%
Industry peers
FMP comparable companies · ranked by market cap
- ITGRBUYInteger Holdings Corporation$4.3BBULLQ 19$126.65+0.06%
- RCUSSELLArcus Biosciences, Inc.$3.0BCRISISQ 17$23.83-7.52%
- BKDSELLBrookdale Senior Living Inc.$2.6BCRISISQ 5$10.89-1.17%
- ETNB89bio, Inc.$2.2B$14.84
- ADUSSELLAddus HomeCare Corporation$2.1BBEARQ 18$114.26-0.82%
- LMATBUYLeMaitre Vascular, Inc.$1.8BRECOVERYQ 20$79.64-1.64%
- ARDTBUYArdent Health Inc.$1.6BRECOVERYQ -11$11.07+1.39%
- AORTSELLArtivion, Inc.$1.0BCRISISQ 3$21.21-1.97%
- PRCTSELLPROCEPT BioRobotics Corporation$1.0BRECOVERYQ -2$17.90-2.40%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on INSP?
- LOPJLB’s latest quantitative signal on Inspire Medical Systems, Inc. (INSP) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is INSP in?
- Inspire Medical Systems, Inc. (INSP) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Inspire Medical Systems, Inc. (INSP) do?
- Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers…